hrp0097p1-245 | Diabetes and Insulin | ESPE2023

Combination of mutations in the HNF1A and ABCC8 genes: clinical polymorphism in members of the same family.

Eremina Irina , Raykina Elizaveta , Titovich Elena , Peterkova Valentina , Laptev Dmitry

Mutations in HNF1A gene underlie the development of maturity onset diabetes of the young type 3 (MODY3). Mutations in ABCC8 gene are the cause of neonatal DM and the rare MODY12, which is clinically similar to MODY3. In these forms of MODY, there is a high sensitivity to sulfonylurea. Patient A, 17 y.o. He was born to woman with gestational DM. At the age of 12.5, fasting hyperglycemia of 13 mmol/l was detected. Insulin therapy was not prescribed due to the parent’s refu...

hrp0097p1-488 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2023

Characteristics of the neonatal period in children with Prader-Willi syndrome

Prylutskaya Veranika , Trebka Ekaterina , Solntsava Anzhalika , Naumchik Irina , Demidovich Tatjana

Background and aim: Prader-Willi Syndrome (PWS) is a rare disease with various clinical signs in different age periods. Early diagnosis has a proven benefit in PWS, allows for timely diet therapy and prevention of obesity, early administration of growth hormone. The purpose of the study is to analyze the features of neonatal adaptation in children with PWS, to evaluate the diagnostic efficacy in the dynamics of the analyzed period.<stron...

hrp0097p2-213 | Adrenals and HPA Axis | ESPE2023

Pseudohypoaldosteronism in congenital anomaly of the kidneys and urinary tract – case presentation

Elkina Stanimira , Bozhanova Venetsiya , Halvadzhiyan Irina , Petrova Chayka

Introduction: Pseudohypoaldosteronism (PHA) is a clinical syndrome characterized by multiorgan or isolated renal tubular resistance to the effects of aldosterone, resulting in hyperkalemia, metabolic acidosis, and normal to high serum aldosterone levels. PHA may be primary (hereditary) or secondary (acquired). Primary forms are subclassified into two: PHA type 1 (salt-wasting) and PHA type 2 (salt-retaining). Secondary forms are typically associated with sever...

hrp0097p2-302 | Late Breaking | ESPE2023

ESPE School Sharing Knowledge for Saving Patients' Lives: Empowering Pediatric Endocrinologists in Armenia

Navasardyan Lusine , Lundberg Elena , Toumasyan Dalar , Muradyan Irina

Background: Practicing as a Pediatric Endocrinologist in Armenia means living in a middle- to low-income country with semi-closed borders associated with war and conflicts. There are therefore fewer opportunities to attend educational events or training at highly rated hospitals worldwide to improve knowledge and skills on pediatric endocrinology. In April 2023 the Endocrine Society of Pediatric Endocrinologists (ESPE) held the ESPE Caucasus & Central Asia...

hrp0095rfc5.3 | Adrenals and HPA Axis | ESPE2022

Towards understanding the metabolic phenotype of glucocorticoid deficiency in 21-hydroxylase deficiency

Bacila Irina , Li Nan , Eachus Helen , Storbeck Karl-Heinz , T Cunliffe Vincent , P Krone Nils

Background: Steroid 21-hydroxylase deficiency (21OHD) is the most common form of congenital adrenal hyperplasia. Patients present with cortisol and aldosterone deficiency as well as with hyperandrogenism, leading to virilisation in females and early adrenarche in both sexes. Requiring life-long glucocorticoid (GC) replacement, patients frequently experience daily fluctuations between GC overexposure and deficiency. Increased prevalence of metabolic disease con...

hrp0095p1-243 | Diabetes and Insulin | ESPE2022

Did Covid-19 pandemic restrictions impact on diabetic care of children and adolescents in Armenia?

Muradyan Irina , Aghajanova Yelena , Janvelyan Tamara , Markosyan Renata , Bayburdyan Gayane , Kalantaryan Lusine , Arakelyan Lusine , Navasardyan Lusine

Background: Type 1 diabetes mellitus (T1DM) is an autoimmune disorder, which occurs mostly among children and adolescents. Armenia is a middle-low income country, where pediatric diabetic care is given centralized in three main centers. The 85-90% of diabetic children and adolescents are followed in the university hospital. During Covid-19 pandemic Armenia was under either lockdown or strict restrictions. The purpose of the current study is to assess the dynam...

hrp0095p2-160 | Growth and Syndromes | ESPE2022

Evaluation of the first year of growth hormone treatment in Prader-Willi Syndrome Patients followed at an Expert Center of Rare Endocrine Diseases

Yordanova Nikolinka , Bazdarska Yuliya , Shishkov Savi , Halvadzhiyan Irina , Galcheva Sonya , Iotova Violeta

Introduction: Prader-Willi syndrome (PWS) is a rare imprinting disorder with evidence of increasing incidence. Treatment with recombinant human growth hormone (rhGH) has been shown to improve growth, body composition and final height. It is officially approved by the US Food and Drug Administration since 2000, but still not official indication in many countries.Aim: The aim of the current study is to assess the results o...

hrp0095p2-252 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2022

Premature ovarian failure in two female patients with 47, XXX karyotype

Halvadzhiyan Irina , Mladenov Wilchelm , Elkina Stanimira , Yordanova Nikolinka , Petrova Chaika , Kovacheva Katia , Boyadzhiev Veselin , Iotova Violeta

Introduction: Premature ovarian failure (POF) is defined as a heterogeneous disease leading to amenorrhea and ovarian failure before the age of 40 years. It is found in 1-3% of women of reproductive age, with some negative consequences such as cardiovascular disease, osteoporosis and sexual dysfunction. Triple X syndrome is characterized by POF with primary or secondary amenorrhea, tall stature, large feet. Girls with triple X syndrome show accelerated growth ...

hrp0092p2-221 | Pituitary, Neuroendocrinology and Puberty | ESPE2019

The Case of Congenital Hypopituitarism Due to Mutation POU1F1 in 3 Azerbaijani Newborn Boys

Arestova Anzhelika , Skorodok Yulia , Ioffe Irina , Kazachenko Natalia , Turkunova Maria , Ivanov Dmitry , Vorozhko Oksana , Filatova Natalia

Background: Growth hormone deficiency in conjunction with the function loss of other anterior pituitary hormones is called combined pituitary hormone deficiency (CPHD). The most common congenital CPHD is caused by mutations in genes: PROP1, POU1F1, HESX1, LHX3, LHX4, OTX2, GLI2, and SOX3. POU1F1 mutations are extremely rare among the Indo-European ethnic type (1% of all cases of congenital hypopituitarism) and more common among the Turkic peoples (7.3%...

hrp0092p2-237 | Pituitary, Neuroendocrinology and Puberty | ESPE2019

Heterozygous OTX2 Deletion in a Boy with Normal Eye Development and Normal Pituitary Function

Boros Emese , Boitsios Gramatina , Vilain Catheline , Balikova Irina , Heinrichs Claudine , Brachet Cécile

Introduction: Orthodenticle homeobox 2 (OTX2) is a transcription factor that plays a critical role in brain and eye development. Heterozygous deleterious mutations in this gene lead to eye malformation such as anophthalmia, microphthalmia, coloboma or optic nerve hypoplasia, normal or hypoplastic pituitary gland and normal or ectopic posterior pituitary gland with isolated growth hormone deficiency or combined pituitary hormone deficiency. There is no...